Melanoma Clinical Trials in Massachusetts

Showing 241-250 of 250 trials

A Study of Volociximab in Metastatic Melanoma

NCT00369395

This is a Phase 2, multicenter, research study determining the effects of an investigational drug called volociximab in metastatic melanoma. The purpose of the study is to compare the clinical benefit and safety of volociximab. Pharmacokinetics and mechanism of action will also be evaluated.

Stage IV Melanoma

Abbott19 participantsStarted Dec 2006

Scottsdale, Arizona, United States • La Jolla, California, United States • Aurora, Colorado, United States +4 more locations

COMPLETEDPhase 226 miles

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

NCT00002860

RATIONALE: Surgery may be effective therapy in treating patients with metastatic melanoma. PURPOSE: This phase II trial is studying how well surgery works in treating patients with metastatic melanoma.

Melanoma (Skin)

SWOG Cancer Research Network77 participantsStarted Nov 1996

Anchorage, Alaska, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +121 more locations

A Study of Volociximab in Metastatic Melanoma

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

Melanoma Trials in Other Cities

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

Long-term Data Collection for Subjects in MDX-010 Studies

Vaccine Therapy for Patients With Stage IV Melanoma

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Other Conditions in Massachusetts